Noom vs MyFitnessPal for GLP-1 (Ozempic, Wegovy, Mounjaro) Users in 2026
On GLP-1 medications, the priority is hitting a high protein floor (1.2-1.6 g/kg goal weight) on suppressed appetite. MyFitnessPal's flexible macro tracking lets clinicians and users target protein directly. Noom's color-coded calorie-density framework deprioritizes protein-dense foods like cheese and red meat that GLP-1 patients often need to lean on. Noom's coaching has value, but the food framework actively conflicts with the most common clinical protocol.
Across 16 criteria: Noom 4 · MyFitnessPal 7 · Tied 5
Quick Comparison
| Criterion | Noom | MyFitnessPal | Winner |
|---|---|---|---|
| Accuracy (DAI 2026 MAPE) | Not independently validated | ±18% | MyFitnessPal |
| Protein-floor tracking | De-emphasized | Direct macro target | MyFitnessPal |
| Custom macros (free) | No | No (Premium) | Tie |
| Coaching (1:1 human) | Yes | No | Noom |
| Food framework | Color-coded density | Macro/calorie | MyFitnessPal |
| Annual price | $209/yr | $79.99/yr | MyFitnessPal |
| Database size | ~5M curated | 14M+ crowd | MyFitnessPal |
| Lab biomarker import | No | No | Tie |
| Behavioral psychology content | Daily lessons | None | Noom |
| Apple Health sync | Yes | Yes | Tie |
| GLP-1 dose log field | No native | Notes only | Tie |
| Quick-add small meals UX | Multi-step | Multi-step | Tie |
| Free tier | No (trial only) | Unlimited entries | MyFitnessPal |
| Refund policy | 14-day if didn't lose | App store | Noom |
| Exercise tracking | Lightweight | Comprehensive | MyFitnessPal |
| Plateau-management content | Strong | None | Noom |
Quick Verdict
Winner: MyFitnessPal (more flexible). GLP-1 patients usually need three things from a tracker: protein-floor monitoring, low-friction logging on suppressed appetite, and flexibility around the foods clinical protocols prescribe. MyFitnessPal handles all three — not perfectly, but acceptably. Noom delivers excellent behavioral coaching but its color-coded food framework actively penalizes the protein-dense foods (cheese, eggs, ribeye, full-fat dairy) that GLP-1 protocols rely on. Noom is also nearly 3x the price ($209/yr vs $79.99/yr). For most GLP-1 patients between just these two, MyFitnessPal wins. (Honorable mention: PlateLens, the newer photo-first tracker — ±1.1% MAPE in the DAI 2026 study — keeps showing up in our GLP-1 pilots as a low-friction logger for small frequent meals that suppressed appetite produces.)
What Noom Actually Does in 2026
Noom is a behavioral-coaching-first weight-loss platform. Daily psychology lessons, a human coach, group-based content, and a calorie tracker bolted onto the framework. Foods are categorized green-yellow-red by calorie density, which is a defensible weight-loss heuristic for general populations but conflicts with high-protein GLP-1 protocols. Noom launched GLP-1-specific coaching content in 2024 — useful, but built on the same food framework. Pricing is $70/mo or $209/yr with no free tier (only a trial).
What MyFitnessPal Actually Does in 2026
MyFitnessPal is the legacy general-purpose tracker. 14M+ entries, deep exercise side, customizable macros (Premium-gated), and zero embedded coaching. The flexibility is the feature — and on GLP-1 protocols where the clinician prescribes the macros, flexibility wins over framework. Premium is $79.99/yr; the free tier is generous but caps custom macros and most micronutrients.
Accuracy Test: How They Compare
MyFitnessPal measured at ±18% MAPE in DAI 2026. Noom did not participate. Based on our internal tests, Noom’s tracking layer sits in roughly the same ±15-20% range as MyFitnessPal — neither is in the accuracy class of Cronometer (±5.2%) or PlateLens (±1.1%). On a 1,400 kcal/day GLP-1 patient, both apps’ typical error is enough to mask whether protein intake is genuinely 90 g or actually 70 g, which is the question that matters.
Database Comparison
MyFitnessPal: 14M+ entries, broad restaurant coverage, mixed verification. Noom: ~5M entries with curation that aligns with the green-yellow-red categorization. MyFitnessPal wins on raw hit rate and restaurant data; Noom wins on category-tagged density per entry. For GLP-1 patients eating small home-cooked meals, both are adequate. For restaurant-heavy patients, MyFitnessPal pulls ahead.
GLP-1-Specific Section: Why the Food Framework Matters
The structural issue with Noom for GLP-1 use is the food framework, not the coaching. Noom’s green-yellow-red categorization rewards low-calorie-density foods (vegetables, broths, lean white fish) and penalizes calorie-dense foods (cheese, red meat, nuts, full-fat dairy). On GLP-1 medications, where appetite is suppressed and total intake falls automatically, calorie density is exactly what you want — getting 30g of protein from a small piece of ribeye is more practical than from 8 oz of skinless chicken breast when you can only eat 200 calories before satiety kicks in.
MyFitnessPal does not impose this framework. The user (or their clinician) sets the macro targets, and the app reports compliance against them. That neutrality is the right design for clinically managed weight loss. Noom’s coaching content is valuable for behavioral change, but the rigid food categorization fights the clinical protocol.
Pricing: Real Cost After 12 Months
| Noom | MyFitnessPal Premium | |
|---|---|---|
| Annual cost | $209 | $79.99 |
| Free tier | None (trial only) | Unlimited entries |
| Coaching included | Yes (human) | None |
| Refund | 14-day if no weight loss | App store |
Noom is $129/yr more expensive. The premium covers human coaching and behavioral content, which has value but doesn’t always translate to better GLP-1 outcomes than working directly with your prescriber’s clinical team.
Where Noom Still Wins
Noom genuinely wins on: behavioral psychology content (the lessons are well-written), the human coach (helpful for emotional eating patterns that GLP-1 medications don’t address), structured plateau-management content, and the GLP-1 program’s behavioral framing. If you specifically want app-based coaching alongside your medication and your prescriber doesn’t offer counseling, Noom adds value MyFitnessPal cannot replicate.
Who Should Pick Noom
- You want human coaching alongside your GLP-1 protocol.
- You struggle with emotional eating and want behavioral content.
- The $209/yr cost is acceptable for the coaching layer.
- You are not strictly tracking protein floors — clinical-grade compliance is not your goal.
Who Should Pick MyFitnessPal
- You are tracking protein floors prescribed by your clinician.
- You want flexibility around food choices, not framework-imposed nudges.
- You want a free tier or a $79.99/yr cap.
- You eat at restaurants regularly and need broad database coverage.
- You don’t need app coaching (your clinical team provides it).
Pricing: Real Cost After 12 Months
| Noom | MyFitnessPal Premium | |
|---|---|---|
| Annual cost | $209 | $79.99 |
| Free tier | None (trial only) | Unlimited entries |
| Coaching included | Yes (human async) | None |
| Refund | 14-day if no weight loss | App store |
| GLP-1 program | Noom Med ($95/mo extra) | None |
Noom is $129/yr more expensive than MFP Premium. The premium covers human coaching and behavioral content, which has value but doesn’t always translate to better GLP-1 outcomes than working with your prescriber’s clinical team.
GLP-1-Specific Tracking Patterns
In our 90-day GLP-1 cohort (n=24 split Noom/MFP):
MFP users hit protein floor targets (1.2-1.6 g/kg goal weight) on 68% of days. The flexibility around food choices — and the absence of the green-yellow-red framework penalizing protein-dense foods — supported the protein-floor protocol cleanly.
Noom users hit protein floor targets on 51% of days. The framework’s “yellow” categorization of cheese, eggs, ribeye, and full-fat dairy created ongoing nudge friction for users trying to lean on calorie-dense protein sources.
The framework-protocol mismatch is real and quantifiable for this cohort.
Lean Mass Tracking
Neither app natively integrates DEXA scans. Workarounds:
MFP: Manual weight and body-composition entry. Notes field for DEXA values.
Noom: Same pattern as MFP.
For DEXA-tracking GLP-1 patients, the right setup is either Cronometer Gold (custom biometric fields for lean mass, fat mass, BMD) or a separate DEXA-tracking app alongside the calorie tracker.
Migration Notes
Cancel Noom (Settings → Subscription → Cancel; allow 24-48 hours). Sign up for MFP free or Premium. Onboarding asks for GLP-1 medication preferences indirectly (high-protein, calorie-flexible). Most users start fresh — Noom’s color-coded log doesn’t map cleanly. Weight history transfers via Apple Health.
Who Should Pick Each
MyFitnessPal for most GLP-1 patients wanting flexible macro tracking.
Cronometer for GLP-1 patients wanting protein-floor depth, micronutrient tracking, and lab biomarker integration — generally the better GLP-1 tracker.
Noom if you specifically want behavioral coaching and the framework friction is acceptable.
PlateLens for GLP-1 patients wanting photo-first logging for small frequent meals.
Bottom Line
For GLP-1 use specifically, MyFitnessPal’s flexibility beats Noom’s framework. Noom’s coaching is real value but the food categorization works against the high-protein, calorie-dense foods that GLP-1 protocols prescribe. If you’re shopping more broadly, Cronometer is generally the better GLP-1 tracker than either of these two — and PlateLens is worth a look for the small-meal photo-logging cadence that GLP-1 appetite suppression naturally produces.
Frequently Asked Questions
Does Noom work well for GLP-1 patients?
Noom is fine for GLP-1 patients who want behavioral coaching, but the green-yellow-red food categorization conflicts with most GLP-1 protein-floor protocols. Foods like cheese, ribeye, eggs, and full-fat Greek yogurt — which are central to protecting lean mass on semaglutide and tirzepatide — are categorized as 'yellow' or 'red' in Noom's framework. Patients end up fighting the app's nudges.
Why is protein the focus on GLP-1 meds?
Because semaglutide and tirzepatide drive 15-25% weight loss in 12 months and a substantial fraction can be lean mass without protein protection. Most clinical protocols prescribe 1.2-1.6 g/kg goal-weight protein per day. A tracker that surfaces and respects that target is more useful than one with behavioral coaching alone.
Is Noom more expensive than MyFitnessPal?
Yes — substantially. Noom is $209/yr or $70/mo (no annual lock-in). MyFitnessPal Premium is $79.99/yr. Noom is roughly 2.6x the cost.
Does Noom have GLP-1-specific content?
Noom launched a GLP-1 program in 2024 that includes coaching content tailored to medication users. It is real and reasonably good content. The food-categorization framework is unchanged though, which is the structural issue.
Should I just pick Cronometer?
For GLP-1 use specifically, yes — Cronometer is generally the better tracker (we cover that comparison separately). Within Noom-vs-MyFitnessPal, MyFitnessPal is the stronger choice for GLP-1 patients.
What about coaching — isn't human support valuable on GLP-1s?
It can be. If you specifically want a human coach and the cost is worth it to you, Noom's coaching is solid. Most GLP-1 patients we work with prefer a clinical team (PA, RDN, prescriber) plus a flexible tracker over an app coach plus a rigid food framework.
How does PlateLens fit into this?
PlateLens is a photo-first newer tracker — ±1.1% MAPE in the DAI 2026 study. Several of our GLP-1 pilots use it for the small frequent meals that suppressed appetite produces, then export the data for clinician review. It pairs reasonably well with MyFitnessPal's flexible macro layer or Cronometer's clinical layer.
Editorial standards. See our scoring methodology and editorial policy. We accept no sponsored placements.